Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TCT 2025

TCT 983: A Novel TTVR System for Tricuspid Regurgitation: 2 Year Follow-up of the Early Compassionate Use Experience

Presenter: Jörg Hausleiter

October 26, 2025

Presentation TCT 2025

Coronary CT Physiology-Derived Virtual Stenting vs. Coronary Angiography for Revascularization Optimization: The CT-COMPASS Trial

Presenter: Kefei Dou

October 25, 2025

Presentation TCT 2023

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

Presenter: Jörg Hausleiter

October 25, 2023

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles J. Davidson

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles Davidson

November 04, 2021

Presentation TCT 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Presenter: Sanjit Jolly

September 28, 2019

Presentation TCT 2019

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Presenter: Robert Welsh

September 26, 2019

Presentation TCT 2018

ACC 2018 Late Breaking Trial #2- COMPASS : What I Liked and What I Question

Presenter: Deepak L. Bhatt, Gregg W. Stone, Kurt Huber

September 23, 2018

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2018

Compassionate Use of the PASCAL System for Transcatheter Tricuspid Repair: A Multicenter First-in-Human Experience

Presenter: Azeem Latib, Georg Nickenig, Ralph Stephan von Bardeleben

September 21, 2018

Presentation TCT 2017

COMPASS Trial: Topline Findings and Practice Implications

Presenter: Robert A. Harrington, Evan A. Stein, Michelle O'Donoghue

November 01, 2017

Presentation TCT 2017

TCT 54: First-in-Human Compassionate Use Results of the Novel PASCAL Transcatheter Mitral Valve Repair System for the Treatment of Severe Mitral Regurgitation

Presenter: Karl-Heinz Kuck, Nicolo Piazza, John G. Webb

October 31, 2017

Advertisement

TCT 983: A Novel TTVR System for Tricuspid Regurgitation: 2 Year Follow-up of the Early Compassionate Use Experience

Coronary CT Physiology-Derived Virtual Stenting vs. Coronary Angiography for Revascularization Optimization: The CT-COMPASS Trial

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

ACC 2018 Late Breaking Trial #2- COMPASS : What I Liked and What I Question

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Compassionate Use of the PASCAL System for Transcatheter Tricuspid Repair: A Multicenter First-in-Human Experience

COMPASS Trial: Topline Findings and Practice Implications

TCT 54: First-in-Human Compassionate Use Results of the Novel PASCAL Transcatheter Mitral Valve Repair System for the Treatment of Severe Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content